Back

Prevalence and reclassification of monoclonal gammopathy in elderly HFpEF patients undergoing ATTR-CM screening: A PATCH-HFpEF sub-study

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Exploring the peripheries in HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pin-Jyun Liao

(Taiwan)

5 More presentations in this session

Presentation thumbnail
Non-invasive pulse-wave-analysis for screening of HFpEF in at-risk patients: findings from the ARTS-PREDICTION study
Doctor J. Gronwald (Goettingen, DE)
Abstract
Presentation thumbnail
Finerenone versus spironolactone in HFpEF patients with type 2 diabetes and CKD: a real-world comparative analysis
Doctor T. Elimihele (Iowa City, US)
Abstract
Presentation thumbnail
Incremental risk stratification using the H2FPEF score in patients with chronic kidney disease and unexplained dyspnea
Mr A. Al-Rubai (Copenhagen, DK)
Abstract
Presentation thumbnail
Diagnostic performance of the H₂FPEF score and cardiovascular burden in patients with chronic kidney disease: a cross-sectional study
Doctor M. Covic (Iasi, RO)
Abstract
Presentation thumbnail
Indoxyl sulfate (IS)-CTSK axis mediates cardiac fibroblast activation in CKD-Related HFpEF
Doctor Y. Zou (Shanghai, CN)
Abstract

Access the full session

Session thumbnail
Exploring the peripheries in HFpEF

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
The prevalence of transthyretin amyloidosis in patients with heart failure with preserved ejection fraction
22 May 2023
thumbnail
Congress Presentation
Unfolding AL amyloidosis: clinical clues and core concepts
19 June 2026
thumbnail
Congress Presentation
Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters
20 June 2025
thumbnail
Congress Presentation
Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources